Wasyluk Weronika, Czop Marcin, Wasyluk Martyna, Janisz-Hezron Joanna, Zwolak Agnieszka
Department of Internal Medicine and Internal Medicine in Nursing, Medical University of Lublin, Poland.
Department of Clinical Genetics, Medical University of Lublin, Poland.
Anaesthesiol Intensive Ther. 2025 Jul 25;57(1):182-194. doi: 10.5114/ait/207612.
The obesity paradox, suggesting improved survival in obese individuals compared to those with normal weight, remains debated, particularly in sepsis. While it has been explored in clinical and experimental settings, conclusive evidence is lacking. This study systematically reviews and meta-analyses the relationship between obesity and survival in murine sepsis models. This systematic review and meta-analysis following PRISMA guidelines included studies from PubMed/Medline (up to January 31, 2025) comparing sepsis survival in obese and non-obese mice. All eligible murine studies were systema-tically reviewed, whereas only those employing diet induced obesity (DIO) and cecal ligation and puncture (CLP) were pooled in the meta-analysis and meta-regression. Twenty-one studies (38 survival experiments) met the criteria: CLP ( = 14), intraperitoneal lipopolysaccharide ( = 7), and other bacterial inoculation models ( = 17). Across all models, obesity increased survival in 10, decreased it in 9, and had no effect in 19 experiments. Quantitative synthesis of 10 CLP-DIO experiments (159 obese vs. 149 lean mice) showed no overall mortality difference ( = 0.391). Meta-regression explained 86% of heterogeneity: later highfat diet (HFD) initiation and longer feeding reduced mortality, whereas older age at sepsis induction increased mortality (all < 0.001). Across the studies, obesity exerted mixed effects; pooled analysis of CLP DIO experiments showed no survival benefit. Variability among studies was associated with time related factors: age at HFD initiation, feeding duration, and age at sepsis induction, highlighting the need to investigate these relationships and to develop a time point standardized CLP DIO sepsis model.
肥胖悖论表明,与正常体重者相比,肥胖个体的生存率更高,但这一观点仍存在争议,尤其是在脓毒症方面。虽然已经在临床和实验环境中进行了探讨,但缺乏确凿的证据。本研究系统回顾并荟萃分析了小鼠脓毒症模型中肥胖与生存率之间的关系。这项遵循PRISMA指南的系统回顾和荟萃分析纳入了来自PubMed/Medline(截至2025年1月31日)的研究,比较了肥胖和非肥胖小鼠的脓毒症生存率。所有符合条件的小鼠研究都进行了系统回顾,而只有那些采用饮食诱导肥胖(DIO)和盲肠结扎穿刺(CLP)的研究被纳入荟萃分析和荟萃回归。21项研究(38个生存实验)符合标准:CLP(n = 14)、腹腔内注射脂多糖(n = 7)和其他细菌接种模型(n = 17)。在所有模型中,肥胖使10项实验中的生存率提高,9项实验中的生存率降低,19项实验中无影响。对10项CLP-DIO实验(159只肥胖小鼠与149只瘦小鼠)的定量综合分析显示,总体死亡率无差异(P = 0.391)。荟萃回归解释了86%的异质性:后期开始高脂肪饮食(HFD)和更长的喂养时间可降低死亡率,而脓毒症诱导时年龄较大则增加死亡率(均P < 0.001)。在各项研究中,肥胖产生了混合效应;CLP DIO实验的汇总分析显示无生存益处。研究之间的变异性与时间相关因素有关:HFD开始时的年龄、喂养持续时间和脓毒症诱导时的年龄,这突出了研究这些关系并开发时间点标准化的CLP DIO脓毒症模型的必要性。